Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Modification02:32

Histone Modification

16.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.1K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis.

Bioscience reports·2017
Same author

Cross-resistance to purified Bt proteins, Bt corn and Bt cotton in a Cry2Ab2-corn resistant strain of Spodoptera frugiperda.

Pest management science·2017
Same author

Abnormal asymmetry in benign epilepsy with unilateral and bilateral centrotemporal spikes: A combined fMRI and DTI study.

Epilepsy research·2017
Same author

Lkb1 maintains T<sub>reg</sub> cell lineage identity.

Nature communications·2017
Same author

Corrigendum: EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance.

Nature communications·2017
Same author

Functional evidence that the self-renewal gene NANOG regulates esophageal squamous cancer development.

Biochemical and biophysical research communications·2017

Related Experiment Video

Updated: Feb 2, 2026

Application of MassSQUIRM for Quantitative Measurements of Lysine Demethylase Activity
07:02

Application of MassSQUIRM for Quantitative Measurements of Lysine Demethylase Activity

Published on: March 11, 2012

13.8K

Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.

Ying Xiang1, Kai Yan2, Qian Zheng1,3

  • 1School of Basic Medical Sciences, Wuhan University, Wuhan, China.

Cancer Research
|November 22, 2018
PubMed
Summary
This summary is machine-generated.

The histone demethylase KDM4B promotes cancer by increasing LINE-1 activity, leading to DNA damage and instability. Inhibiting KDM4B reduces LINE-1 expression and damage, offering new therapeutic strategies.

More Related Videos

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

4.1K
Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
05:44

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening

Published on: January 26, 2024

1.3K

Related Experiment Videos

Last Updated: Feb 2, 2026

Application of MassSQUIRM for Quantitative Measurements of Lysine Demethylase Activity
07:02

Application of MassSQUIRM for Quantitative Measurements of Lysine Demethylase Activity

Published on: March 11, 2012

13.8K
Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

4.1K
Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
05:44

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening

Published on: January 26, 2024

1.3K

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genomics

Background:

  • Histone demethylase KDM4B is overexpressed in many cancers.
  • KDM4B's oncogenic role is linked to H3K9me3 demethylation, affecting gene expression and genome stability.
  • Global analysis of KDM4B's effect on H3K9me3 distribution was lacking.

Purpose of the Study:

  • To investigate the genome-wide effect of KDM4B on H3K9me3 distribution.
  • To determine KDM4B's role in regulating LINE-1 elements.
  • To explore the therapeutic potential of KDM4B inhibition in cancer.

Main Methods:

  • Genome-wide analysis of H3K9me3 distribution in cancer cells.
  • Assessment of LINE-1 expression and retrotransposition activity under varying KDM4B levels.
  • Pharmacologic inhibition of KDM4B in breast cancer cell lines.

Main Results:

  • H3K9me3 is enriched in long interspersed nuclear element-1 (LINE-1) regions.
  • KDM4B directly regulates LINE-1 expression and retrotransposition, particularly in young LINE-1 elements.
  • KDM4B overexpression enhances LINE-1 copy number, retrotransposition, and associated DNA damage.
  • High KDM4B levels in breast cancer correlate with increased LINE-1 activity and DNA damage.
  • KDM4B inhibition reduces LINE-1 expression and DNA damage in relevant cancer cells.

Conclusions:

  • KDM4B is a novel regulator of LINE-1 retrotransposition.
  • KDM4B overexpression contributes to tumorigenesis through LINE-1-induced DNA damage.
  • Targeting KDM4B offers a potential strategy for cancer prevention and therapy.